95% of the inflammation is gone
The Regulatory Background In late 2023, the FDA placed 19 widely used peptides on its Category 2 restricted list, effectively barring compounding pharmacies from preparing them
Experience a noticeable lift in energy, mood, and overall wellness no stimulants, no downtime, just real results
More frequent dosing, either as eight smaller boluses or as continuous infusion, proved more effective in raising IGF-1 levels than two large bolus doses
Administered as a subcutaneous injectable or a nasal spray
Administered via intramuscular injection, this formula allows for rapid absorption and noticeable results